Biotech entrepreneur Kiran Mazumdar-Shaw has called for establishing a standard-setting regulatory body for medical devices, as non-certified ones put patients at serious risk. “I certainly think we need to have a standard setting regulatory body for medical devices,” the Chairperson and MD of biotechnlogy firm Biocon told PTI. “Precision of any medical intervention is critical as we cannot afford to have non-certified medical devices in the market as we will put patients at serious risk,” she said. On the National Pharmaceutical Pricing Authority's recent decision fixing price caps on coronary stents, Mazumdar-Shaw said price control on stents need to factor in the design and material of their construction.